<DOC>
	<DOC>NCT00388050</DOC>
	<brief_summary>The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.</brief_summary>
	<brief_title>Diabetes Medication Choice</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Have a diagnosis of type 2 diabetes mellitus of any duration; cpeptide test not required Use 1 or 2 oral hypoglycemic agents; not using insulin therapy Are not pregnant Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 79.5% Recognize their primary care provider as their main diabetes care provider Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decisionmaking (per provider?s assessment) Have no plans to relocate out of town in the next 6 months Enrolment is open to males and females of diverse racial backgrounds</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Decision aid, diabetes, primary care</keyword>
</DOC>